Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Verpakung: Inert-Paket für Übersee-Versand
Transport: Ocean,Land,Air,Express
Unterstützung über: 5000KGS MONTHLY
Hafen: QINGDAO,SHANGHAI,BEIJING
Saracatinib (AZD0530) ist ein orales kleines Molekül SRC-Inhibitor, das von AstraZeneca entwickelt wurde. AZD0530 hat die Wirkung der zunehmenden Knochendichte und die Reduzierung von Schmerzen für die Knochenmetastasierung von malignen Tumoren.
Product |
LOXO-292 |
CAS |
2152628-33-4 |
MF |
C29H31N7O3 |
MW |
525.6 |
Produktgruppe : API-Zwischenprodukte > LOXO-292 Mittelstufe
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.